Anticancer agent 222

• Description:

  Anticancer agent 222 (Compound 19) is an orally active anticancer agent that exhibits significant anticancer activity against Huh7, FOCUS, SNU475, SNU182, HepG2, and Hep3B cells (IC50 = 2.9–9.3 μM) [1].

• UNSPSC:

  12352005

• Target:

  Drug Derivative

• Type:

  Reference compound

• Related Pathways:

  Others

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/anticancer-agent-222.html

• Smiles:

  FC (F) (F) C (C=C1) =CC=C1C2=NC3=C (N=CN=C3N2C4CCCC4) N (CC5) CCN5C6=CC=C (C (F) (F) F) C=C6

• Molecular Formula:

  C28H26F6N6

• Molecular Weight:

  560.54

• References & Citations:

  [1]Fatih Polat M, et al. Synthesis and cytotoxicity of novel 6,8,9-trisubstituted purine analogs against liver cancer cells. Bioorg Med Chem Lett. 2024;106:129775.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  9007-83-4